Sign in

CIK 0001094038

  • Non-accelerated filer
  • Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880277072
Phone
+1 713-400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 58 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-08-15 Agopyan Nadia VP, Regulatory Affairs Grant or award · Employee Stock Option (right to buy) +200,000 200,000
2019-08-14 Hoang Peter L. President and CEO Purchase +10,000 $4.62 $46K 189,711
2019-08-06 ELMS STEVE Director Grant or award · Stock Option (right to buy) +12,500 12,500
2019-05-09 Eansor Norman David Director Grant or award +7,260 7,260
2019-05-09 Wilson John Robert Director Grant or award +7,260 6,068,043
2019-05-09 Laskow-Pooley David Director Grant or award +7,260 25,543
2019-05-09 Wasserman Frederick Gerald Director Grant or award +7,260 25,543
2018-11-27 Kim Anthony H. Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +400,000 400,000
2018-10-19 Hoang Peter L. Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +1,359,855 1,359,855
2018-10-19 Hoang Peter L. Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2018-10-19 Vera Juan Director Grant or award · Employee Stock Option (Right to Buy) +500,000 500,000
2018-10-19 Loiacono Michael Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2018-10-17 Eansor Norman David Director Grant or award · Non-Employee Director Stock Option (Right to Buy) +12,500 12,500
2018-10-17 Wilson John Robert Director Grant or award · Non-Employee Director Stock Option (Right to Buy) +12,500 12,500
2018-10-16 Silverman Joshua Director Grant or award +4,106 17,221
2018-10-16 Grisewood Sherry Director Grant or award +4,106 19,582
2018-10-16 Reddish Mark Director Grant or award +4,106 36,110
2018-10-16 Laskow-Pooley David Director Grant or award +5,168 18,283
2018-10-16 Wasserman Frederick Gerald Director Grant or award +5,168 18,283

Page 6 of 6 · 119 trades